Skip to content
Government NT, Medical Health Aged Care

AMSANT welcomes NT Government action on syphilis outbreak

Aboriginal Medical Services Alliance Northern Territory (AMSANT) 2 mins read

The Aboriginal Medical Services Alliance Northern Territory (AMSANT) welcomes the NT Government’s decision to commission a dedicated Incident Management Team (IMT) to respond to the ongoing syphilis outbreak — a long overdue but critical step in addressing this public health issue.

Syphilis is a sexually transmissible infection that can be difficult to detect without a test. Known as “the great imitator,” its symptoms are often confused with other health conditions — or may disappear quickly, even though the infection remains. Without regular screening, it’s easy for people to have syphilis without realising they’re unwell.

“Syphilis is a serious public health issue that has quietly worsened for more than a decade,” said Barbara Molanus, Sexual Health Coordinator at AMSANT.

“The decision to commission an IMT is a step in the right direction that can bring a renewed focus to community-wide testing.

“Testing is key to identifying cases early. By starting treatment straight away and treating partners, we can prevent further transmission and the potentially devastating effects of untreated syphilis on babies and people who go on to develop tertiary syphilis.”

Since 2013, syphilis cases have steadily increased across the Territory.

Ms Molanus said Aboriginal community-controlled health services (ACCHS) have been on the frontline of the response for more than 12 years, delivering testing, treatment, education and contact tracing in challenging and under-resourced settings.

“The good news is that our sector has been leading the way in managing this outbreak — and we are now in the strongest position to advise government on what works,” she said.

“Our member services bring cultural knowledge, clinical expertise and trusted relationships with community — and we stand ready to guide this next phase of the response.”

AMSANT looks forward to working in partnership with the NT Government to ensure this response is community-led, evidence-based, and backed by the resources needed to stop the spread.

 


Contact details:

Amy Price, 0437 027 156

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 17/12/2025
  • 06:00
Leukaemia Foundation

Leukaemia Foundation welcomes South Australian Government commitment to establish dedicated CAR T therapy service

The Leukaemia Foundation has welcomed the announcement by theMalinauskas Labor Government that South Australia is establishing a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer – marking a major advancement in cancer care in the State. The new service, expected to commence by mid-2026, will significantly improve access to this highly specialised, life-saving treatment and reduce the need for South Australians to travel interstate for care. Leukaemia Foundation Chief Executive Officer Chris Tanti said the announcement represented a huge win for blood cancer patients and their families. “This is a landmark step…

  • Medical Health Aged Care
  • 17/12/2025
  • 01:10
WW International Inc.

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that lastNEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience bringing together comprehensive support for members on GLP-1 medications, personalised nutrition, behavioural support, coaching, and community within a redesigned app and digital platform. Built for a new era of weight management and long-term health, the new integrated offering delivers coordinated, evidence-based…

  • Medical Health Aged Care
  • 16/12/2025
  • 12:11
Esco Aster Pte. Ltd.

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

SINGAPORE–BUSINESS WIRE– Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.